Glucose metabolism (FDG)

Ongoing clinical trials and approved products targeting Glucose metabolism (FDG), in radioligand therapy and PET/SPECT imaging. Data as of 26 October 2026.

0ongoing therapy trials
112ongoing imaging trials
1approved products

Target note

Full name
Glucose metabolism (GLUT transporters, hexokinase)
Nature
FDG enters the cell through GLUT transporters, is phosphorylated by hexokinase and then trapped, without going further down glycolysis.
Normal expression
Brain, myocardium (depending on fasting), kidneys and urinary tract, active muscles, brown fat, bone marrow and gastrointestinal tract.
Disease expression
Most aggressive cancers, all the more so when proliferation is high.
Value
The most widely used PET tracer: oncology (staging, treatment response), neurology (dementias, epilepsy), cardiology (viability, sarcoidosis), infection and inflammation (prolonged fever, vasculitis, prosthetic infections).
Approaches
[18F]FDG; analogues explored for SPECT ([99mTc]CNDG).
Indications explored
Lymphomas, lung, head and neck and gastrointestinal cancers, melanoma; dementias; myocardial viability; unexplained prolonged fever, vasculitis.
Points of caution
Inflammatory and infectious false positives; false negatives in poorly glycolytic tumors (well-differentiated NETs, prostate cancer, well-differentiated hepatocellular carcinoma); dependence on blood glucose and fasting.

Approved products

FDG (many manufacturers)[18F]fludeoxyglucoseMultiplesmarketedUS EU FR JP

Ongoing imaging trials · 112Open in the radar →

TrialPhaseStatusSponsorCountries
[18F]FDGNCT01394679 · Non-small-cell lung cancerPhase 3Not yet recruitingCell>Point LLC1
[18F]FDGNCT05015881 · Psychiatry and addictionPhase 3By invitationUniversity of Pennsylvania1
HISTIOGEN · [18F]FDGNCT04943211 · OtherPhase 3Active, not recruitingAnna Raciborska1
[18F]FDGNCT07245849 · OtherPhase 3Not yet recruitingOttawa Heart Institute Research Corporation0
[18F]FDGNCT04143516 · Solid tumors (multiple indications)Phase 3RecruitingMemorial Sloan Kettering Cancer Center1
[18F]FDG2025-522349-23-00 · Neuroinflammation and multiple sclerosisPhase 3RecruitingAmsterdam UMC Stichting1
STB-XTR-003 · [18F]FDGNCT07443696 · Ischemic heart diseasePhase 2RecruitingSinotau Pharmaceutical Group1
CRAFT · [18F]FDGNCT06335888 · Atherosclerosis and vesselsPhase 2RecruitingInsel Gruppe AG, University Hospital Bern1
[18F]FDGNCT05710328 · BreastPhase 2Active, not recruitingECOG-ACRIN Cancer Research Group2
[18F]FDG2023-509923-42-00 · BreastPhase 2RecruitingMedica Scientia Innovation Research S.L.5
[18F]FDG2023-504145-31-00 · BreastPhase 2RecruitingNarodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie-Panstwowy Instytut Badawczy1
[18F]FDGNCT04275453 · Healthy volunteers (dosimetry, biodistribution)Phase 2RecruitingUniversity of Pennsylvania1
[18F]FDGNCT04316117 · BreastPhase 2Active, not recruitingECOG-ACRIN Cancer Research Group3
[18F]FDGNCT07471776 · BreastPhase 2RecruitingFudan University1
[18F]FDGNCT06956391 · Solid tumors (multiple indications)Phase 2RecruitingAkiva Mintz1
GRAIL · [18F]FDGNCT06050694 · LymphomaPhase 2RecruitingUniversity Health Network, Toronto1
IMPACT · [18F]FDGNCT05308888 · Atherosclerosis and vesselsPhase 2RecruitingUniversity Hospital, Brest1
[18F]FDG2023-510506-41-00 · Small-cell lung cancerPhase 2RecruitingTheraOp gGmbH1
[18F]FDGNCT07848243 · BreastPhase 2RecruitingPeking University Cancer Hospital & Institute1
[18F]FDGNCT07508852 · Small-cell lung cancerPhase 2RecruitingPeking University First Hospital1
[18F]FDGNCT04692103 · BreastPhase 2Active, not recruitingUniversity of Washington1
[18F]FDG2023-508478-27-00 · LymphomaPhase 2RecruitingEuropean Organisation For Research And Treatment Of Cancer7
[18F]FDGNCT06502691 · BreastPhase 2RecruitingUniversity of Washington1
[18F]FDG2024-516131-28-00 · NETs and neuroendocrine carcinomas (other)Phase 2RecruitingRigshospitalet1
[18F]FDG2024-514353-30-00 · Inflammatory diseasesPhase 1RecruitingAssistance Publique Hopitaux De Paris1
[18F]FDGNCT05549024 · Prostate – otherPhase 1RecruitingPeking Union Medical College Hospital1
[18F]FDGNCT02285192 · GynecologicalPhase 1Active, not recruitingMemorial Sloan Kettering Cancer Center1
[18F]FDGNCT06632860 · NETs and neuroendocrine carcinomas (other)Phase 1RecruitingPeking Union Medical College Hospital1
[18F]FDGNCT06385652 · MyelomaPhase 1RecruitingPeking University First Hospital1
[18F]FDGNCT04219904 · GynecologicalPhase 1Active, not recruitingM.D. Anderson Cancer Center1
[18F]FDGNCT05892393 · MyelomaPhase 1RecruitingRobert Flavell, MD, PhD1
[18F]FDGNCT07023861 · BreastPhase 1By invitationAffiliated Hospital of Jiangnan University1
[18F]FDGNCT06717113 · MyelomaPhase 1RecruitingPeking University First Hospital1
[18F]FDGNCT07838649 · OtherPhase 1Not yet recruitingWashington University School of Medicine1
[18F]FDGNCT07023848 · BreastPhase 1By invitationAffiliated Hospital of Jiangnan University1
[18F]FDGNCT06014515 · Atherosclerosis and vesselsPhase 1RecruitingUniversity of California, Davis1
[18F]FDGNCT07604207 · Atherosclerosis and vesselsPhase 1Not yet recruitingMassachusetts General Hospital0
[18F]FDGNCT05876858 · OtherPhase 1Active, not recruitingUniversity of California, Davis1
[18F]FDGNCT06914999 · Atherosclerosis and vesselsPhase 1RecruitingEmory University1
[18F]FDGNCT02213497 · Stomach / esophagusPhase 1Active, not recruitingAbramson Cancer Center at Penn Medicine1
[18F]FDGNCT04362644 · Inflammatory diseasesPhase 1RecruitingUniversity of Alabama at Birmingham1
[18F]FDGNCT07301801 · Solid tumors (multiple indications)Phase 1RecruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology1
[18F]FDGNCT06453915 · Neuroinflammation and multiple sclerosisPhase 1RecruitingUniversity of California, Davis1
MVTEP2/SOME2 · [18F]FDGNCT04304651 · Solid tumors (multiple indications)No phaseActive, not recruitingUniversity Hospital, Brest2
NVALT31-PET · [18F]FDGNCT06082492 · Small-cell lung cancerNo phaseRecruitingRadboud University Medical Center1
MONITOR-RCT · [18F]FDGNCT06877949 · BreastNo phaseRecruitingOdense University Hospital3
CARTEP · [18F]FDGNCT07029295 · Heart failure and cardiomyopathiesNo phaseNot yet recruitingAssistance Publique - Hôpitaux de Paris1
PERPETUAL · [18F]FDGNCT07130344 · BreastNo phaseNot yet recruitingCentre Paul Strauss1
PREDICT · [18F]FDGNCT07454096 · Atherosclerosis and vesselsNo phaseNot yet recruitingFundacion Clinic per a la Recerca Biomédica1
CET-PET-PUO · [18F]FDGNCT07816783 · OtherNo phaseRecruitingPost Graduate Institute of Medical Education and Research, Chandigarh1
SMART-PET · [18F]FDGNCT07884487 · BreastNo phaseActive, not recruitingCliniques universitaires Saint-Luc- Université Catholique de Louvain1
[18F]FDGNCT04478318 · MelanomaNo phaseActive, not recruitingUniversity of California, Davis1
[18F]FDGNCT06017973 · EpilepsyNo phaseRecruitingUniversitaire Ziekenhuizen KU Leuven1
INCOGNITO · [18F]FDGNCT05733416 · Stroke and traumaNo phaseRecruitingOttawa Hospital Research Institute1
PanTumPET · [18F]FDGNCT06842615 · Solid tumors (multiple indications)No phaseRecruitingComenius University1
[18F]FDGNCT00950430 · Alzheimer's disease and cognitive disordersNo phaseBy invitationMayo Clinic1
[18F]FDGNCT06511323 · OtherNo phaseNot yet recruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's0
[18F]FDGNCT06715020 · BreastNo phaseRecruitingPeking University Cancer Hospital & Institute1
[18F]FDGNCT07509125 · Alzheimer's disease and cognitive disordersNo phaseRecruitingUniversitaire Ziekenhuizen KU Leuven1
TREN · [18F]FDGNCT02386709 · Solid tumors (multiple indications)No phaseActive, not recruitingCentre Georges Francois Leclerc1
[18F]FDGNCT05730608 · BreastNo phaseRecruitingVestre Viken Hospital Trust1
KETO-FDG Lung · [18F]FDGNCT07479095 · Non-small-cell lung cancerNo phaseRecruitingFondazione del Piemonte per l'Oncologia1
[18F]FDGNCT07859800 · Bacterial infectionsNo phaseNot yet recruitingNational Institute of Allergy and Infectious Diseases (NIAID)1
DETECT · [18F]FDGNCT04892667 · OtherNo phaseActive, not recruitingAssistance Publique - Hôpitaux de Paris1
NUK-RBD · [18F]FDGNCT06629207 · Alzheimer's disease and cognitive disordersNo phaseRecruitingInsel Gruppe AG, University Hospital Bern1
INSIGHT-2 · [18F]FDGNCT05806697 · Alzheimer's disease and cognitive disordersNo phaseRecruitingInstitut National de la Santé Et de la Recherche Médicale, France1
GlioConnect · [18F]FDGNCT07628257 · Brain (glioma, medulloblastoma…)No phaseNot yet recruitingCentre Paul Strauss1
DECIDER · [18F]FDGNCT04846933 · GynecologicalNo phaseRecruitingTurku University Hospital1
LAPC · [18F]FDGNCT05191940 · Pancreas (adenocarcinoma)No phaseRecruitingEBG MedAustron GmbH1
CHORD1 · [18F]FDGNCT05641753 · Diabetes and obesityNo phaseRecruitingNYU Langone Health1
[18F]FDGNCT05436093 · Solid tumors (multiple indications)No phaseRecruitingPeking University Cancer Hospital & Institute1
EndEOTEP · [18F]FDGNCT05989152 · Endocarditis and cardiac infectionsNo phaseRecruitingAssistance Publique - Hôpitaux de Paris1
[18F]FDGNCT06429891 · Stomach / esophagusNo phaseRecruitingHua Zhu1
TEP Margins · [18F]FDGNCT07285564 · Head and neckNo phaseRecruitingCentre Henri Becquerel1
[18F]FDGNCT04804371 · Gastroenteropancreatic NETsNo phaseActive, not recruitingUniversity Health Network, Toronto1
[18F]FDGNCT04901884 · OtherNo phaseRecruitingUniversity Health Network, Toronto1
[18F]FDGNCT05463913 · Non-small-cell lung cancerNo phaseRecruitingUniversity Medical Center Groningen1
TOTAL · [18F]FDGNCT06739473 · Diabetes and obesityNo phaseRecruitingTurku University Hospital1
SONImage · [18F]FDGNCT04125277 · BreastNo phaseActive, not recruitingThe Netherlands Cancer Institute1
[18F]FDGNCT04702022 · KidneyNo phaseRecruitingUniversity of Liege1
[18F]FDGNCT06197698 · Parkinson's disease and parkinsonian syndromesNo phaseRecruitingNational Taiwan University Hospital1
[99mTc]CNDG (glucose analogue)NCT06362304 · Brain (glioma, medulloblastoma…)No phaseRecruitingPeking Union Medical College Hospital1
[18F]FDGNCT07782944 · LymphomaNo phaseRecruitingGuilin Medical University, China1
[18F]FDGNCT07458906 · NETs and neuroendocrine carcinomas (other)No phaseRecruitingThe First Affiliated Hospital of Xiamen University1
[18F]FDGNCT01093612 · BreastNo phaseActive, not recruitingCity of Hope Medical Center1
[18F]FDGNCT02293954 · BreastNo phaseActive, not recruitingCity of Hope Medical Center1
HPVDNA02 · [18F]FDGNCT03853915 · GynecologicalNo phaseRecruitingUniversity Health Network, Toronto1
TEP-ANTI-PD1 · [18F]FDGNCT03888950 · MelanomaNo phaseRecruitingCentre Hospitalier Universitaire de Nice1
MIM · [18F]FDGNCT04349358 · MyelomaNo phaseRecruitingCentre Georges Francois Leclerc1
[18F]FDGNCT04569591 · AdrenalNo phaseRecruitingNational Institute of Neurological Disorders and Stroke (NINDS)1
[18F]FDGNCT05321316 · Bladder / urothelialNo phaseRecruitingPeking University Cancer Hospital & Institute1
[18F]FDGNCT05775939 · OtherNo phaseRecruitingThomas Jefferson University1
DAF-PMID · [18F]FDGNCT06565936 · Psychiatry and addictionNo phaseRecruitingThe First Affiliated Hospital of Dalian Medical University1
[18F]FDGNCT07589101 · BreastNo phaseNot yet recruitingPeking University Cancer Hospital & Institute1
[18F]FDGNCT04251481 · Head and neckNo phaseActive, not recruitingNYU Langone Health1
ENCEPHATAIP · [18F]FDGNCT06079294 · OtherNo phaseRecruitingAssistance Publique - Hôpitaux de Paris1
[18F]FDGNCT07087106 · Neuroinflammation and multiple sclerosisNo phaseRecruitingBrigham and Women's Hospital1
MetaAD_FTD · [18F]FDGNCT07100470 · Alzheimer's disease and cognitive disordersNo phaseNot yet recruitingCentre Hospitalier St Anne0
ThorPET · [18F]FDGNCT05693363 · Non-small-cell lung cancerNo phaseRecruitingUniversity Hospital, Ghent1
NVUCVR · [18F]FDGNCT06797661 · Atherosclerosis and vesselsNo phaseRecruitingErasme University Hospital1
[18F]FDGNCT02226276 · BreastNo phaseActive, not recruitingCity of Hope Medical Center1
TEPDEP · [18F]FDGNCT06452290 · Psychiatry and addictionNo phaseNot yet recruitingCentral Hospital, Nancy, France0
[18F]FDGNCT06647368 · Alzheimer's disease and cognitive disordersNo phaseRecruitingNicolai Jacob Wewer Albrechtsen1
APEMMAV-NR · [18F]FDGNCT07569887 · Alzheimer's disease and cognitive disordersNo phaseRecruitingUniversity Hospital, Montpellier1
LAVA-FLOW · [18F]FDGNCT07628075 · Atherosclerosis and vesselsNo phaseNot yet recruitingImperial College London1
[18F]FDGNCT07727317 · Solid tumors (multiple indications)No phaseNot yet recruitingShanghai Zhongshan Hospital0
[18F]FDGNCT06630845 · Solid tumors (multiple indications)No phaseActive, not recruitingUniversity of California, San Francisco1
HELP · [18F]FDGNCT07295171 · Solid tumors (multiple indications)No phaseActive, not recruitingBritish Columbia Cancer Agency1
[18F]FDGNCT05844306 · Solid tumors (multiple indications)No phaseActive, not recruitingCity of Hope Medical Center1
[18F]FDGNCT07677787 · Small-cell lung cancerNo phaseRecruitingThe First Affiliated Hospital of Xiamen University1
DEPLETE · [18F]FDGNCT06232889 · OtherNo phaseRecruitingUMC Utrecht1
ICEBATH · [18F]FDGNCT07048405 · OtherNo phaseRecruitingUniversity of Edinburgh1

Cite this page

Glucose metabolism (FDG). Theranostic Atlas, LaRadiopharmacie.fr. Data as of 26 October 2026. https://theranosticatlas.com/target/glucose-metabolism-fdg/ (accessed [date]).

A monitoring tool with no regulatory value: check every item at its source.